Sore Throat News and Research

RSS

Reflux disease diagnosis: an interview with Professor Peter Dettmar, Managing Director of RD Biomed Limited

Generally speaking, reflux has been a major chronic issue for probably the last 40 or 50 years. When you look at the global population, depending on which country we're talking about, around 20% to 40% of individuals have reflux disease within their populations.

23 Dec 2013

College students not only bring dirty socks but also mononucleosis to home

One of the hallmarks of heading home for winter break is the enormous amounts of laundry college students bring as a welcome home present for Mom and Dad. But the dirty socks might not be the only unwelcome guest they transport home. They might also bring mononucleosis, better known as mono.

6 Dec 2013

In states not expanding Medicaid, hospitals face a squeeze as federal funds dry up

The New York Times examines the dilemma for some safety-net hospitals that will not see a drop in the uninsured but will lose federal money that used to help pay for those patients.

12 Nov 2013

First Edition: November 11, 2013

Today's headlines include reports about how Republicans are positioning themselves to capitalize on the health law's implementation difficulties in the upcoming election season.

11 Nov 2013

Research roundup: Pricing and the SHOP exchange; health use in rural vs. urban areas; the health law and AIDS care

Each week, KHN compiles a selection of recently released health policy studies and briefs.

11 Nov 2013

New 'clinical score' test for patients with sore throats reduces antibiotics usage nearly 30%

A new 'clinical score' test for patients with sore throats could reduce the amount of antibiotics prescribed and result in patients feeling better more quickly, research in the British Medical Journal shows.

11 Nov 2013

First generic versions of Aciphex delayed-release tablets get FDA approval for GERD treatment

The U.S. Food and Drug Administration today approved the first generic versions of Aciphex (rabeprazole sodium) delayed-release tablets, used to treat gastroesophageal reflux disease in adults and adolescents (ages 12 and up).

10 Nov 2013

Paracetamol, ibuprofen or combination of both provide no advantage for respiratory tract infections

Questions have been raised about the advice given to patients with a cold and sore throat, in research published in the British Medical Journal.

4 Nov 2013

Sore throat clinical score boosts effective antibiotic use

Research published in the BMJ shows that clinical score is as good a guide for antibiotic prescribing as rapid streptococcal antigen detection tests in patients presenting to primary care with sore throat.

28 Oct 2013

Luden partners with Thompson Square to celebrate "Voices Worth Hearing"

Luden's, the soothing throat drop loved by voices everywhere, today announced a new partnership with Thompson Square, the reigning Academy of Country Music and Country Music Association "Vocal Duo of the Year."

19 Oct 2013

Opsumit drug receives FDA approval to treat adults with pulmonary arterial hypertension

The U.S. Food and Drug Administration today approved Opsumit (macitentan), a new drug to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive and debilitating disease that can lead to death or the need for lung transplantation.

19 Oct 2013

FDA accepts, files Genentech's sBLA for subcutaneous use of Xolair in people with CIU

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration has accepted and filed the company's supplemental Biologics License Application for subcutaneous use of Xolair (omalizumab) in people with Chronic Idiopathic Urticaria who remained symptomatic despite treatment with H1-antihistamine therapy at approved doses.

11 Oct 2013

Research roundup: Health law's effects on consumer spending; Mass. experience finds increased use of laparoscopic surgery

The authors find that average out-of-pocket spending is expected to decrease for all groups considered in the analysis, although decreases in out-of-pocket spending will be largest for those who would otherwise be uninsured.

5 Oct 2013

Doctors prescribe antibiotics for sore throats and acute bronchitis, say researchers

A vast majority of people who see their doctors for sore throats or acute bronchitis receive antibiotics, yet only a small percentage should, according to analyses of two major national surveys being presented at IDWeek 2013-. Those illnesses usually are caused by viruses, and antibiotics - which only treat bacterial infections - do not help.

5 Oct 2013

Diabetes puts you at increased risk of flu-related complications

There are certain groups of people who are at risk of serious flu complications each year, including those with diabetes.

30 Sep 2013

Boehringer Ingelheim, Lilly present post-hoc analysis data from linagliptin clinical trials at EASD 2013

Boehringer Ingelheim and Eli Lilly and Company today announced results from two post-hoc, pooled analyses of data from placebo-controlled clinical trials, which examined the safety of the dipeptidyl peptidase-4 inhibitor linagliptin in adults with type 2 diabetes.

24 Sep 2013

TGA of Australia approves Vertex Pharmaceuticals' KALYDECO for cystic fibrosis

Vertex Pharmaceuticals Incorporated today announced that the Therapeutic Goods Administration of Australia has approved KALYDECO (ivacaftor) for people with cystic fibrosis ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator gene.

10 Jul 2013

Viewpoints: Health care's hidden consensus; Examining the fee-for-service payment system; Alternative medicine's allure

The politicians' consensus is that health care reform shouldn't alter or disrupt the way the majority of Americans get their insurance today. ... The policy consensus, though, is that the status quo is actually the problem, and that it deserves to be threatened, undermined and replaced as expeditiously as possible. Wonks of the left and right disagree on what that replacement should look like. But they're united in regarding employer-provided coverage as an unsustainable relic (Ross Douthat, 7/6).

9 Jul 2013

Linagliptin significantly reduces blood glucose levels in T2D patients with moderate to severe renal impairment

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced results from a new study in which linagliptin demonstrated statistically significant reductions in blood glucose levels (HbA1c) after 12 weeks (the study's primary endpoint) in adults with type 2 diabetes (T2D) with moderate to severe renal impairment, compared with placebo. Most patients had T2D for more than ten years (76 percent) and were on insulin (86 percent).

24 Jun 2013

Alios begins oral dosing of ALS-8176 in Phase 1 clinical trial for RSV infection

Alios BioPharma, Inc. today announced that it has begun oral dosing of ALS-8176 in a Phase 1 clinical trial. ALS-8176 is a structurally novel, anti-respiratory syncytial virus (RSV) nucleoside analog that is being developed for the treatment of acute RSV infection.

31 May 2013

Sore Throat News and Research

Reflux disease diagnosis: an interview with Professor Peter Dettmar, Managing Director of RD Biomed Limited

College students not only bring dirty socks but also mononucleosis to home

In states not expanding Medicaid, hospitals face a squeeze as federal funds dry up

First Edition: November 11, 2013

Research roundup: Pricing and the SHOP exchange; health use in rural vs. urban areas; the health law and AIDS care

New 'clinical score' test for patients with sore throats reduces antibiotics usage nearly 30%

First generic versions of Aciphex delayed-release tablets get FDA approval for GERD treatment

Paracetamol, ibuprofen or combination of both provide no advantage for respiratory tract infections

Sore throat clinical score boosts effective antibiotic use

Luden partners with Thompson Square to celebrate "Voices Worth Hearing"

Opsumit drug receives FDA approval to treat adults with pulmonary arterial hypertension

FDA accepts, files Genentech's sBLA for subcutaneous use of Xolair in people with CIU

Research roundup: Health law's effects on consumer spending; Mass. experience finds increased use of laparoscopic surgery

Doctors prescribe antibiotics for sore throats and acute bronchitis, say researchers

Diabetes puts you at increased risk of flu-related complications

Boehringer Ingelheim, Lilly present post-hoc analysis data from linagliptin clinical trials at EASD 2013

TGA of Australia approves Vertex Pharmaceuticals' KALYDECO for cystic fibrosis

Viewpoints: Health care's hidden consensus; Examining the fee-for-service payment system; Alternative medicine's allure

Linagliptin significantly reduces blood glucose levels in T2D patients with moderate to severe renal impairment

Alios begins oral dosing of ALS-8176 in Phase 1 clinical trial for RSV infection

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News